#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15826	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2028	773.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	927	C	886	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	900	C,G,T	850,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1684	1684	A	975	A	920	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	894	C	823	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	894	A	853	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	904	C,G	854,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	0	HET	.	.	.	A790G	.	790	790	A	1137	1137	A	894	A,G	657,195	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	814.6	0	HET	.	.	.	G1685A	.	1685	1685	G	2032	2032	G	961	G,A	493,421	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2170	folP	855	855	100.0	folP.l15.c4.ctg.1	1675	129.1	1	SNP	p	R229S	0	.	.	685	687	CGC	1223	1225	CGC	213;215;212	C;G;C,G	200;201;195,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5922	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3409	173.2	1	SNP	p	S91F	0	.	.	271	273	TCC	616	618	TCC	182;182;182	T;C,T;C	174;175,1;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5922	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3409	173.2	1	SNP	p	D95G	0	.	.	283	285	GAC	628	630	GAC	176;177;176	G;A,G;C	167;164,1;166	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5922	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3409	173.2	1	SNP	p	D95N	0	.	.	283	285	GAC	628	630	GAC	176;177;176	G;A,G;C	167;164,1;166	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1770	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1353	130.3	1	SNP	p	G45D	1	.	.	133	135	GAC	487	489	GAC	239;239;239	G;A;C	224;224;229	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	882	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1150	76.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5740	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2820	202.2	1	SNP	p	D86N	0	.	.	256	258	GAC	532	534	GAC	248;246;247	G;A;C	239;230;236	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5740	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2820	202.2	1	SNP	p	S88P	0	.	.	262	264	TCC	538	540	TCC	243;243;243	T;C;C	225;226;228	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4530	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2692	167.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1538	1540	GGC	224;227;228	G;G;C	212;216;211	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	1928	1930	CTG	141;143;141	C,G;T;G	105,5;99;105	.	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1205	1207	GCA	243;249;249	G;C;A	226;229;231	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1208	1210	ATC	249;254;255	A;T;C	229;236;238	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1220	1222	GTG	244;243;247	G,T;T;G	227,1;225;227	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1220	1222	GTG	244;243;247	G,T;T;G	227,1;225;227	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1724	1726	ACC	197;198;198	A;C;C	183;186;187	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1778	1780	GTG	186;184;186	G;T,G;G	171;151,6;172	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1778	1780	GTG	186;184;186	G;T,G;G	171;151,6;172	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1901	1903	GGC	159;160;159	G;G;C,A	149;153;151,1	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4134	penA	1749	1749	99.94	penA.l6.c30.ctg.1	2326	176.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1910	1912	GGC	160;160;159	G;G;C	148;151;148	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5868	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3051	191.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1598	1600	CCG	214;216;217	C;C;G	198;205;203	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2376	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1780	133.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	366	368	GGC	151;150;149	G,T;G;C	139,1;139;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2376	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1780	133.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	171	C	162	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	0	.	p	.	0	G120N	NONSYN	358	360	GGC	624	626	AAC	252;248;245	A;A;C	238;233;232	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	0	.	p	.	0	E212G	NONSYN	634	636	GAA	900	902	GGA	250;251;254	G;G;A	237;238;238	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	0	.	p	.	0	Y216_S217del	DEL	646	646	T	912	912	T	252	T	243	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1140	1142	AAT	250;252;252	A;A,G;T	238;239,1;238	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	1	SNP	p	A121D	1	.	.	361	363	GAC	627	629	GAC	243;239;241	G;A;C	233;225;232	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3050	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1524	198.7	1	SNP	p	D121N	0	.	.	361	363	GAC	627	629	GAC	243;239;241	G;A;C	233;225;232	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11132	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4820	230.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1222	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	973	124.3	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	252;255;254	A;T;G	238;242;241	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
